Cim Investment Management Inc Amicus Therapeutics, Inc. Transaction History

Cim Investment Management Inc

$332 Million
Q3 2024

A detailed history of Cim Investment Management Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Cim Investment Management Inc holds 15,963 shares of FOLD stock, worth $155,958. This represents 0.05% of its overall portfolio holdings.

Number of Shares

15,963

Previous 15,963 -0.0%

Holding current value

$155,958

Previous $158,000 7.59%

% of portfolio

0.05%

Previous 0.05%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$9.04 - $11.75 $34,342 - $44,638	-3,799 Reduced 19.22%	15,963 $158,000
Q1 2023 May 16, 2023	BUY	$10.91 - $13.54 $7,418 - $9,207	680 Added 3.56%	19,762 $219,000
Q1 2022 May 17, 2022	SELL	$7.89 - $12.48 $17,531 - $27,730	-2,222 Reduced 10.43%	19,082 $181,000
Q4 2021 May 19, 2022	SELL	$9.82 - $12.44 $209,205 - $265,021	-21,304 Reduced 50.0%	21,304 $246,000
Q4 2021 Feb 02, 2022	BUY	$9.82 - $12.44 $209,205 - $265,021	21,304 Added 100.0%	42,608 $449,000
Q1 2021 May 20, 2021	BUY	$9.2 - $23.86 $106,416 - $275,988	11,567 Added 118.79%	21,304 $210,000
Q4 2020 Feb 17, 2021	SELL	$13.47 - $24.89 $131,224 - $242,478	-9,742 Reduced 50.01%	9,737 $225,000
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $3,622 - $4,465	281 Added 1.46%	19,479 $275,000
Q2 2020 Aug 14, 2020	SELL	$8.86 - $15.69 $18,109 - $32,070	-2,044 Reduced 9.62%	19,198 $290,000
Q1 2020 May 22, 2020	SELL	$6.63 - $11.16 $132,600 - $223,200	-20,000 Reduced 48.49%	21,242 $196,000
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $308,490 - $443,351	41,242 New	41,242 $402,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.74B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.

Account

Cim Investment Management Inc Amicus Therapeutics, Inc. Transaction History